ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

NCI Advisory Board Approves Three Concepts

December 19, 2014

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013